![The Price of Deception: How a Duke Patient was Harmed in Potti's Fraudulent Trials](https://cdn.cancerletter.com/media/2024/01/29011322/41-20-Joyce-Shoffner.jpg)
![The Price of Deception: How a Duke Patient was Harmed in Potti's Fraudulent Trials](https://cdn.cancerletter.com/media/2024/01/29011322/41-20-Joyce-Shoffner.jpg)
Cover Story
Free
Anil Potti, in a Duke commercial advertising the trial Shoffner joined.Joyce Shoffner would never have predicted that Duke University, an institution she revered and at one time worked for, would put her in a breast cancer clinical trial testing a fraudulent technology.
In Brief
Drugs & Targets
Trending Stories
- Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement. - At Lung SPORE Workshop, experts reflect on the significance of discovery of EGFR mutations two decades ago
- The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop